Genetic polymorphism in the 3′-untranslated region of the E-cadherin gene is associated with risk of different cancers
✍ Scribed by Yan Li; Yuanjia Tang; Rongmiao Zhou; Donglan Sun; Yanan Duan; Na Wang; Zhifeng Chen; Nan Shen
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 153 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0899-1987
- DOI
- 10.1002/mc.20765
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The genetic polymorphisms in E‐cadherin gene (CDH1) may affect invasive/metastatic disease development by altering gene transcriptional activity. In this paper, we investigated the effect of 3′‐UTR +54C/T polymorphism (rs1801026) in CDH1 gene on the risk and progression of several common cancers. Multiple completely independent case‐control analyses of 1081 cancer patients with esophageal squamous cell carcinoma (ESCC), gastric cardiac adenocarcinoma (GCA), non‐small‐cell lung cancer (NSCLC), and cervical cancer and 1131 control subjects in northern Chinese populations. The results showed that the carriers with T allele were significantly decreased the risk of developing GCA, NSCLC, and cervical cancer, with an adjusted odds ratio of 0.67 (95% CI = 0.48–0.91), 0.68 (95% CI = 0.49–0.92), and 0.66 (95% CI = 0.48–0.92), respectively. There were no association between the frequency of genotype and the clinicopathological features of ESCC, GCA, and NSCLC, but the frequency of T allele was significantly lower in patients of stage III cervical cancer (P = 0.026). These results suggested that the 3′‐UTR +54C/T polymorphism in CDH1 may be a marker for genetic susceptibility of cancer. © 2011 Wiley Periodicals, Inc.
📜 SIMILAR VOLUMES
E-cadherin plays a major role in intercellular adhesion, cell polarity and tissue architecture. We determined the relative risk of PCa associated with a previously reported C/A SNP at -160 bp relative to the transcription-start site of the E-cadherin gene promoter. Eighty-two PCa patients and 188 co
## Abstract Caspase‐3 (CASP‐3) is a primary effector CASP that executes programmed cell death, and it plays an important role in the development and progression of cancer. Polymorphisms in the __CASP‐3__ gene may influence CASP‐3 production and/or activity, thereby modulating the susceptibility to